KLİNİĞİMİZDE MULTİPLE SKLEROZ TANISI İLE İZLENEN HASTALARIN KLİNİK DEMOGRAFİK VERİLERİNİN ÖZÜRLÜLÜK İLE İLİŞKİSİ

Abstract

Amaç: Multipl Skleroz (MS) genç erişkinlerde özürlülüğün sık nedenlerden birisidir. Bu çalışmada MS tanısı ile takip edilen hastaların klinik ve demografik verilerini engellilik açısından değerlendirmeyi amaçladık. Gereç ve Yöntemler: Bu retrospektif çalışmada MS polikliniğinde 9 Temmuz-9 Eylül 2022 tarihleri arasındaki iki aylık dönemde izlenen 195 hasta, hastane kayıt sistemi aracılığıyla değerlendirildi. Bulgular: Genişletilmiş engellilik durum ölçeği (EDSS) değerlendirmesi ile cinsiyet açısından fark saptanmadı (p>0,05). Doğal olarak progresif grupta EDSS daha yüksek bulundu. Ailesinde MS olan hastalarda sporadik vakalara göre EDSS farkı saptanmadı (p>0,05). Çalışmamızda medeni durum ile engellilik arasında evli olanlarda daha yüksek EDSS yönünde bir ilişki saptandı (p<0,05). Daha yüksek eğitim düzeyi daha düşük EDSS ile ilişkili bulundu. Kronik hastalıkların varlığı EDSS artışı ile uyumlu bulundu (p<0,05). İstihdam açısından bakıldığında ise çalışan grubun EDSS’si daha düşük bulunurken, çalışmak isteyip çalışamayan ve kendi isteğiyle çalışmayan grupta EDSS daha yüksek bulundu (p<0,05). Sigara içmek de engellilik gelişimi için bir risk faktörü olarak bulundu (p<0,05). Sonuç: Hastaların yaşam kalitelerinin arttırılması için aile, istihdam, eğitim, sigara içimi, yaşam tarzı önerileri ile gibi alanlarda farkındalığın oluşması klinik demografik verilerin paylaşılması ile mümkün olabilir. Hastalarının sosyal anlamda desteklenmesi bireysel ve toplumsal yükü azaltabilir.

Keywords

• Multiple skleroz
• özürlülük
• klinik demografik veriler

Clinical Demographic Data and Disability in Patients Diagnosed with Multiple Sclerosis Followed in Our Clinic

Abstract

Objective: Multiple sclerosis (MS) is one of the leading causes of disability among young people worldwide. This study aimed to evaluate the clinical and demographic characteristics of patients who were followed up with a diagnosis of MS in terms of disability. Material and Methods: This retrospective study evaluated 195 patients who applied to the MS outpatient clinic between July 9, 2022 and September 9, 2022, using the hospital data system. Results: There was no difference in the evaluation of Expanded Disability Status Scale (EDSS) in terms of gender (p>0.05). Naturally, EDSS was found to be higher in the progressive group. There was no difference in EDSS in patients with MS in their families compared to sporadic cases (p>0.05). Our study found a correlation between marital status and disability, with a higher EDSS among those who were married. (p>0.05). Higher education level was associated with lower EDSS (p<0.05). The presence of chronic diseases was found to be compatible with an increase in EDSS. In terms of employment, the EDSS of the working group was lower, but the EDSS was higher in the group who wanted to work but could not work and who did not work by choice (p<0.05). Smoking was also found to be a risk factor for developing disability (p<0.05). Conclusion: Improving patients’ quality of life may be possible by raising awareness in areas such as family, employment, education, smoking, and lifestyle, through the sharing of clinical and demographic data. Social support of MS patients can reduce individual and social burden.

Keywords

• Multiple sclerosis
• disability
• clinical demographic data

References

1. Dobson R, Giovannoni G. Multiple sclerosis a review. Eur J Neurol. 2019;26(1):27-40.
2. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. The Lancet Neurol. 2010;9:520–532.
3. Gökçe ŞF, Çiğdem B, Nemmezi KS, et al. Prevalence of multiple sclerosis in an urban population of Sivas province in Turkey. Turk J Med Sci. 2019; 49(1):288–294.
4. Akdemir N, Terzi M, Arslan N, Onar M. Prevalence of multiple sclerosis in the middle black sea region of turkey and demographic characteristics of patients. Noro Psikiyatr Ars. 2017;54(1):11-14.
5. Deangelis TM, Miller A. Diagnosis of multiple sclerosis. Handb Clin Neurol. 2014;122:317-342.
6. Klineova S, Lublin FD. Clinical course of multiple sclerosis. Cold Spring Harb Perspect Med. 2018;8(9):a028928.
7. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173.
8. Adamczyk-Sowa M, Gębka-Kępińska B, Kępiński M. Multiple sclerosis risk factors. Wiad Lek. 2020;73(12 cz 1):2677-2682.

9. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-1444.
10. Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816-1821.
11. Lane J, Ng HS, Poyser C, Lucas RM, Tremlett H. Multiple sclerosis incidence: A systematic review of change over time by geographical region. Mult Scler Relat Disord. 2022;63:103932.
12. Midgard R. Incidence and prevalence of multiple sclerosis in Norway. Acta Neurol Scand Suppl. 2012;(195):36-42.
13. Marrie RA, Fisk JD, Stadnyk KJ, et al. CIHR Team in the epidemiology and ımpact of comorbidity on multiple sclerosis. The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada. Can J Neurol Sci. 2013;40(6):824-831.
14. Visser EM, Wilde K, Wilson JF, Yong KK, Counsell CE. A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city. J Neurol Neurosurg Psychiatry. 2012;83(7):719-724.
15. Langer-Gould AM, Gonzales EG, Smith JB, Li BH, Nelson LM. Racial and ethnic disparities in multiple sclerosis prevalence. Neurology. 2022;98(18):e1818-e1827.
16. Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Rev Neurol (Paris). 2016;172(1):3-13.
17. Boström I, Landtblom AM. Does the changing sex ratio of multiple sclerosis give opportunities for intervention? Acta Neurol Scand. 2015;132(199):42-45.
18. Houzen H, Kano T, Kondo K, Takahashi T, Niino M. The prevalence and incidence of multiple sclerosis over the past 20 years in northern Japan. Mult Scler Relat Disord. 2023;73:104696.
19. Simpson-Yap S, Maddox D, Reece J, ve ark. Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022. Mult Scler Relat Disord. 2023;77:104845.
20. Tharakan JJ, Ranganath PC, and Poovathoor CJ. Multiple sclerosis in Oman. Neurosciences Journal. 2005;10.3: 223-225.
21. Voskuhl RR. The effect of sex on multiple sclerosis risk and disease progression. Mult Scler. 2020 Apr;26(5):554-560.
22. Kara F, Göl MF, Boz C. Determinants of disability development in patients with multiple sclerosis. Arq Neuropsiquiatr. 2021 Jun;79(6):489-496.
23. Deiva K. Pediatric onset multiple sclerosis. Rev Neurol (Paris). 2020;176(1-2):30-36.
24. Naseri A, Nasiri E, Sahraian MA, Daneshvar S, Talebi M. Clinical features of late-onset multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord. 2021;50:102816.
25. Klineova S, Lublin FD. Clinical course of multiple sclerosis. Cold Spring Harb Perspect Med. 2018;8(9):a028928.
26. Pfleger CC, Flachs EM, Koch-Henriksen N. Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study. Mult Scler. 2010;16(7):878-882.
27. Harrison T, Stuifbergen A, Adachi E, Becker H. Marriage, impairment, and acceptance in persons with multiple sclerosis. West J Nurs Res. 2004;26(3):266-285.
28. Zeytin Demiral G, Betaş Akın S. İç Ege bölgesinde familyal multipl sklerozun klinik ve demografik özellikleri. Kocatepe Tıp Derg. 2024:25:189-193.
29. Salehi Z, Almasi-Hashiani A, Sahraian MA, Eskandarieh S. Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999-2018. Mult Scler Relat Disord. 2020;43:102178.
30. Balcerac A, Louapre C. Genetics and familial distribution of multiple sclerosis: A review. Rev Neurol (Paris). 2022 J;178(6):512-520.
31. Nielsen NM, Westergaard T, Rostgaard K, et al. Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol. 2005. 15;162(8):774-778.
32. Weinshenker BG, Bulman D, Carriere W, Baskerville J, Ebers GC. A comparison of sporadic and familial multiple sclerosis. Neurology. 1990;40(9):1354-1358.
33. Faraji F, Mohaghegh P, Talaie A. Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran. Mult Scler Relat Disord. 2022;68:104231.
34. Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017;13(1):25-36.
35. Ostolaza A, Corroza J, Ayuso T. Multiple sclerosis and aging: comorbidity and treatment challenges. Mult Scler Relat Disord. 2021;50:102815.
36. Kavaliunas A, Danylaite Karrenbauer V, Hillert J. Socioeconomic consequences of multiple sclerosis-A systematic literature review. Acta Neurol Scand. 2021;143(6):587-601.
37. Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J; MSCOI Study Group; European Multiple Sclerosis Platform. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler. 2017;23(8):1123-1136.
38. Rosso M, Chitnis T. Association between cigarette smoking and multiple sclerosis: A review. JAMA Neurol. 2020;77(2):245–253.
39. Arneth B. Multiple sclerosis and smoking. Am J Med. 2020;133(7):783-788.